Mexico Active Pharmaceutical Ingredient (API) Market Overview, 2027

Mexico API Market Size, Share, Trend & Market Analysis By Type, By Distribution Channel, By End User, Competition, Forecast & Opportunities.

"The API manufacturing sector in Mexico has experienced significant growth in recent years, attracting both domestic and foreign investment. Many multinational pharmaceutical companies have set up manufacturing facilities in Mexico to take advantage of the country's competitive advantages and access to the North American market. Additionally, Mexico has also seen the development of local API manufacturers, contributing to the growth of the industry. Mexico has a well-developed and highly skilled labor force in the pharmaceutical and chemical sectors. The country has a strong tradition in chemical manufacturing, which provides a solid foundation for API production. Mexico has experienced a steady expansion of its pharmaceutical industry, driven by factors such as population growth, rising healthcare demands, and an increasing focus on research and development. The expansion of API production is intimately related to the changing healthcare environment thus creating new opportunities for API manufacturers who can produce high-quality APIs that can help to treat disease. Mexico is a cost-effective site for API manufacture since it has lower manufacturing costs than many wealthy nations. A worldwide regulatory framework for the production of pharmaceuticals is followed in Mexico. The governing body in charge of monitoring pharmaceutical products and making sure that Good Manufacturing Practices (GMP) are followed is the Federal Commission for the Protection against Sanitary Risk (COFEPRIS). API manufacturing operations are supported by Mexico's well-developed infrastructure, which includes industrial parks, transportation systems, and utilities. The United States-Mexico-Canada Agreement (USMCA), which improves trade and market access for pharmaceutical goods made in Mexico, is one of a number of free trade accords with which Mexico is affiliated. Manufacturers are increasingly focusing on environmentally friendly practices by implementing green chemistry principles. This involves using sustainable raw materials, minimizing waste generation, and optimizing chemical processes to reduce environmental impact. According to the report titled ""Mexico Active Pharmaceutical Ingredients Market Outlook, 2027"" published by Bonafide Research, the market is expected to grow exorbitantly over the forecast period. Though synthetic APIs are widely used to manufacture drugs, biotech APIs are expected to grow rapidly over the forecast period. The availability of cutting-edge technologies, research facilities, and academic institutions fosters innovation in API manufacturing processes and techniques. The captive API segment accounted for the major market share and is expected to grow at a steady CAGR over the forecast period. The manufacturing market in Mexico has been experiencing steady growth over the years. The demand for APIs is primarily driven by the increasing need for generic drugs, advancements in drug development, and the rising prevalence of chronic diseases. The United States has one of the largest generic drug markets globally. The manufacturing of API drugs in Mexico is distributed across various segments, but the highest manufacturing volume typically occurs in the generic drug segment. Generic APIs are expected to be in demand over the forecast period as the branded API segment's demands are declining. This is due to the consolidation in the pharma industry and various drugs going off-patent. Due to a rise in over-the-counter drugs and the lower cost of generic drugs, it is expected to lure consumers. The increasing number of cardiovascular diseases, diabetes, respiratory diseases, cancers, and other chronic diseases, which are long-lasting and require the patient to consume the drugs on a daily basis, drive the demand for cheaper alternatives to save costs. Thus, the demand for generic API will rise in future years coupled with government incentives. The cardiovascular diseases segment accounts for the largest application due to increasing heart-related diseases worldwide. Rising awareness, preventive treatment, and government measures are further expected to drive future demand for API. On the other hand, oncology applications are expected to grow rapidly over the forecast period due to the changing lifestyles of millennials and the growing number of cancer patients in recent years. The metabolic disorders caused by sedentary lifestyles and hormonal imbalances created in the human body are the factors increasing the risks of these diseases. Diabetes is another chronic disease that is on the rise among the populace in the country. The COVID-19 pandemic brought attention to the value of indigenous medication production capacity and supply chain resilience. The pandemic also caused disruptions to the supply chain for APIs. This was due to a number of factors, including factory closures, travel restrictions, and shortages of raw materials. In 2020 the manufacturing of drugs decreased by -2.80% due to supply chain logistics which were at a standstill. However, the future markets are projected to grow exorbitantly as they have recovered from the pandemic shocks. Many manufacturing units in China were shut down due to a lack of raw materials and the pandemic effects which affected the world markets for API. Also, the decrease in demand for pharmaceuticals for certain elective procedures has also led to a decline in the market's growth in 2020. These disruptions made it difficult for API manufacturers to obtain the materials they needed to produce APIs, which led to shortages of some APIs. Due to this factor, there is now more interest in promoting and funding domestic API production to maintain a steady supply of life-saving medications in the event of catastrophes or breakdowns in the global supply chain.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

API manufacturers in Mexico are pursuing to meet the growing demand for pharmaceutical products. The industry continues to evolve and adapt to advancements in science, technology, and patient needs. API manufacturers are increasingly partnering with research institutions, startups, and other industry stakeholders to foster collaboration and open innovation. By sharing knowledge, resources, and expertise, they can accelerate the development of new ideas and bring innovative products to market more rapidly. API manufacturers are also using new technologies, such as artificial intelligence (AI) and machine learning, to improve their manufacturing processes. These technologies are used to optimize process parameters, predict yields, and identify potential problems. Considered in this report ? Geography: United States (US) ? Historic Year: 2016 ? Base year: 2021 ? Estimated year: 2022 ? Forecast year: 2027 Aspects covered in this report United States • Active Pharmaceutical Ingredients Market with its value, forecast, and segments • Application wise Active Pharmaceutical Ingredients distribution • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Prashant Tiwari

Prashant Tiwari

Research Analyst

Based on a synthesis of Active Pharmaceutical Ingredients in the report • Synthetic API • Biotech API Based on the drug type of Active Pharmaceutical Ingredients in the report • Branded API • Generic API Based on the type of manufacture of Active Pharmaceutical Ingredients in the report • Captive API • Merchant API

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Prashant Tiwari

By Therapeutic Application Type in the report • Communicable Diseases • Oncology • Diabetes • Cardiovascular Disease • Pain management • Respiratory Diseases • Other Therapeutic Applications The approach of the report This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual reports of companies, and analyzing government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the pharmaceutical industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry. Please get in touch with our sales team to find out more."

Table of Contents

  • Table of Content
  • 1. Executive Summary
  • 2. Introduction
  • 2.1. Market Definition
  • 2.2. Market Scope & Segmentation
  • 2.3. Research Methodology
  • 3. Mexico Macro Economic Indicators
  • 4. Mexico Active Pharmaceutical Ingredients Market Category Analysis
  • 4.1. Key findings
  • 4.2. Market Drivers
  • 4.3. Market Restraints
  • 4.4. Policies & Certification
  • 4.5. Opportunities
  • 4.6. Value Chain Analysis
  • 4.7. Key Developments - 2021
  • 5. Mexico Active Pharmaceutical Ingredients Market Trends
  • 6. Mexico Active Pharmaceutical Ingredients Market Overview
  • 6.1. Market Size By Value
  • 6.2. Market Share
  • 6.2.1. By Synthesis Type
  • 6.2.2. By Therapeutic Application
  • 6.2.3. By Type of Manufacture
  • 7. Mexico Active Pharmaceutical Ingredients Market Segmentations
  • 7.1. Mexico Active Pharmaceutical Ingredients Market, By Synthesis Type
  • 7.1.1. Mexico Active Pharmaceutical Ingredients Market Size, By Synthetic API, 2016 - 2027F
  • 7.1.2. Mexico Active Pharmaceutical Ingredients Market Size, By Biotech API, 2016 - 2027F
  • 7.2. Mexico Active Pharmaceutical Ingredients Market, By Therapeutic Application
  • 7.2.1. Mexico Active Pharmaceutical Ingredients Market Size, By Communicable Diseases, 2016 - 2027F
  • 7.2.2. Mexico Active Pharmaceutical Ingredients Market Size, By Oncology, 2016 - 2027F
  • 7.2.3. Mexico Active Pharmaceutical Ingredients Market Size, By Diabetes, 2016 - 2027F
  • 7.2.4. Mexico Active Pharmaceutical Ingredients Market Size, By Cardiovascular Disease, 2016 - 2027F
  • 7.2.5. Mexico Active Pharmaceutical Ingredients Market Size, By Pain management, 2016 - 2027F
  • 7.2.6. Mexico Active Pharmaceutical Ingredients Market Size, By Respiratory Diseases, 2016 - 2027F
  • 7.2.7. Mexico Active Pharmaceutical Ingredients Market Size, By Other Therapeutic Applications, 2016 - 2027F
  • 7.3. Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacture
  • 7.3.1. Mexico Active Pharmaceutical Ingredients Market Size, By Captive API, 2016 - 2027F
  • 7.3.2. Mexico Active Pharmaceutical Ingredients Market Size, By Merchant API, 2016 - 2027F
  • 8. Mexico Active Pharmaceutical Ingredients Market Opportunity Assessment
  • 8.1. By Active Pharmaceutical Ingredients, 2022F to 2027F
  • 8.2. By Therapeutic Application, 2022F to 2027F
  • 8.3. By Type of Manufacture, 2022F to 2027F
  • 9. Competitive Landscape
  • 9.1. Porter's Five Forces
  • 9.2. Company Profiles
  • 9.2.1. Company 1
  • 9.2.2. Company 2
  • 9.2.3. Company 3
  • 9.2.4. Company 4
  • 9.2.5. Company 5
  • 9.2.6. Company 6
  • 9.2.7. Company 7
  • 9.2.8. Company 8
  • 10. Strategic Recommendations
  • 11. Disclaimer

List of Table
Table 1: Mexico Active Pharmaceutical Ingredients Market Size of Synthetic API (2016 to 2027F) (In USD billion)
Table 2: Mexico Active Pharmaceutical Ingredients Market Size of Biotech API (2016 to 2027F) (In USD billion)
Table 3: Mexico Active Pharmaceutical Ingredients Market Size of Communicable Diseases (2016 to 2027F) (In USD billion)
Table 4: Mexico Active Pharmaceutical Ingredients Market Size of Oncology (2016 to 2027F) (In USD billion)
Table 5: Mexico Active Pharmaceutical Ingredients Market Size of Diabetes (2016 to 2027F) (In USD billion)
Table 6: Mexico Active Pharmaceutical Ingredients Market Size of Cardiovascular Disease (2016 to 2027F) (In USD billion)
Table 7: Mexico Active Pharmaceutical Ingredients Market Size of Pain management (2016 to 2027F) (In USD billion)
Table 8: Mexico Active Pharmaceutical Ingredients Market Size of Respiratory Diseases (2016 to 2027F) (In USD billion)
Table 9: Mexico Active Pharmaceutical Ingredients Market Size of Other Therapeutic Applications (2016 to 2027F) (In USD billion)
Table 10: Mexico Active Pharmaceutical Ingredients Market Size of Captive API (2016 to 2027F) (In USD billion)
Table 11: Mexico Active Pharmaceutical Ingredients Market Size of Merchant API (2016 to 2027F) (In USD billion)
Table 12: Key Facts of Company 1
Table 13: Key Facts of Company 2
Table 14: Key Facts of Company 3
Table 15: Key Facts of Company 4
Table 16: Key Facts of Company 5
Table 17: Key Facts of Company 6
Table 18: Key Facts of Company 7
Table 19: Key Facts of Company 8

List of Figure
Figure 1: Mexico Active Pharmaceutical Ingredients Market Size By Value 2016 to 2027F (In USD billion)
Figure 2: Mexico Active Pharmaceutical Ingredients Market Share By Volume By Synthesis Type (2016, 2021 & 2027F)
Figure 3: Mexico Active Pharmaceutical Ingredients Market Share By Volume By Therapeutic Application (2016, 2021 & 2027F)
Figure 4: Mexico Active Pharmaceutical Ingredients Market Share By Type of Manufacture (2016, 2021 & 2027F)
Figure 5: Market Attractiveness Index, By Synthesis Type
Figure 6: Market Attractiveness Index, By Therapeutic Application
Figure 7: Market Attractiveness Index, By Type of Manufacture
Figure-8: Porter's Five Forces Meter of Active Pharmaceutical Ingredients Industry in Mexico

Why Bonafide Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology
92%
Data Collection Techniques
97%
Our Research Team & Data Sourcing
93%
Data Science & Analytical Tools
81%
Data Visualization & Presentation Skills
86%
Project/ Report Delivery & After Sales Services
88%
Logo

Mexico Active Pharmaceutical Ingredient (API) Market Overview, 2027

Contact usWe are friendly and approachable, give us a call.